Pharmaceutical company focused on innovation to improve global health
H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019
H.R. 3 - Lower Drug Costs Now Act
S. 2543 - Prescription Drug Pricing Reduction Act

no specific bills, Medicare Part D, Value based purchasing, Medicare Part B, 340B, Medicare coverage & reimbursement, insulin, Senate and Finance Drug bill S. 1416 - Affordable Prescriptions For Patients Act of 2019 
S. 1895 - Lower Health Care Costs Act 
H.R. 3 - Lower Drug Costs Now Act
S. 2543 - Prescription Drug Pricing Reduction Act
S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
S. 3129 - Lower Costs, More Cures Act of 2019
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
H.R. 6201 - Families First Coronavirus Response Act
S. 3548 - CARES Act

no specific bills, non-interference, dormant therapies, drug shortages, prescription drug access and affordability, transparency, insulin policy, authorized generics, 340B
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TARPLIN, DOWNS & YOUNG, LLC
1212 New York Avenue, NW, Suite 750, Washington, DC, 20005, US
RAISSA H DOWNS JENNIFER B YOUNG MICHELLE P EASTON ELIZABETH T MURRAY CHARLOTTE SPEARS IVANCIC PAMELA SMITH EMILY H MURRY RAISSA H DOWNS JENNIFER B YOUNG MICHELLE P EASTON ELIZABETH T MURRAY CHARLOTTE SPEARS IVANCIC PAMELA SMITH EMILY H MURRY